ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Biggest gainers & losers of the day: Paper, brokerage stocks fly high; Natco Pharma tanks 7%
Paper stocks and brokerage stocks have been on a roll today, with multiple counters hitting the buyer circuit. Multiple stocks fell after the stock exchanges sought clarification on them.
Announcement as on 07 July 2021

Natco Pharma Q4 results: Net profit dips 43% to Rs 53 crore
Total income during the fourth quarter stood at Rs 360 crore, down from Rs 477 crore in the fourth quarter of the financial year 2019-20, the drugmaker said in a regulatory filing.
Announcement as on 17 June 2021

Natco Pharma's marketing partner gets USFDA nod for anti-cancer drug
Natco Pharma said based on the ANDA filing date, the company believes that it is eligible for 180 days of sole generic marketing exclusivity for the 10 mg strength and shared 180 days of generic marketing exclusivity for the 60 mg strength of the product a
Announcement as on 14 June 2021

Natco Pharma surges 20%, hits new high on USFDA nod for cancer drug
The company has received approval from the US health regulator for the generic version of Celgene's multiple myeloma drug, Revlimid (Lenalidomide) capsules in the US
Announcement as on 24 May 2021

Natco Pharma gets American drug regulator's nod for generic cancer treatment drug
Natco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celgene, now part of Bristol-Myers Squibb, who sells the product under the brand name 'Revlimid', it added.
Announcement as on 22 May 2021

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 789.55
  • 12Day Average: 788.68
  • 20Day Average: 801.68
  • 50Day Average: 831.01
  • 100Day Average: 874.7
  • 150Day Average: 943.99
  • 200Day Average: 931.32

524816 Indicators & signals

Indicator MACD (12,26,9)

792.78, 806.12, -14.51
Indicator MACD is in negative zone

Indicator ADX (14)

20.75, 11.83, 18.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 782.50 780.00 to 801.15 -0.67% 0.73 times
29 Thu Oct 2026 787.75 786.00 to 799.15 -0.71% 0.66 times
28 Wed Oct 2026 793.35 779.95 to 801.85 -0.09% 2.83 times
27 Tue Oct 2026 794.05 784.65 to 798.00 0.5% 0.45 times
26 Mon Oct 2026 790.10 782.85 to 796.15 -0.27% 0.63 times
23 Fri Oct 2026 792.20 778.00 to 796.70 0.85% 1.25 times
22 Thu Oct 2026 785.50 774.00 to 789.00 0.08% 0.99 times
21 Wed Oct 2026 784.90 779.45 to 808.95 -1.98% 0.55 times
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 1.78 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.25 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.61 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 0.88 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top